Sam Brusco, Associate Editor03.26.22
Spinoff news attracted the most readers this week: Becton Dickinson announced the spinoff of its embecta diabetes business would be completed on the first of April. Precision medicine company InnoSIGN also proclaimed its separation from Philips due to an $8 million financing round.
In new product news, Integra LifeSciences launched its new NeuroGen 3D resorbable implant to help repair peripheral nerves. In M&A news, TouchPoint began a deal to acquire custom medial arm and wall mount maker ICWUSA, and completed a deal for custom medical cart, mounding systems, telemedicine solutions, and patient entertainment systems maker Parity Medical.
In case you missed them, here are MPO's top stories of the week:
In new product news, Integra LifeSciences launched its new NeuroGen 3D resorbable implant to help repair peripheral nerves. In M&A news, TouchPoint began a deal to acquire custom medial arm and wall mount maker ICWUSA, and completed a deal for custom medical cart, mounding systems, telemedicine solutions, and patient entertainment systems maker Parity Medical.
In case you missed them, here are MPO's top stories of the week:
1. BD's embecta Diabetes Spinoff to be Completed April 1
2. InnoSIGN Completes Spinoff from Philips
3. Integra Rolls Out NeuraGen 3D Nerve Guide Matrix
4. TouchPoint to Buy ICWUSA, Completes Parity Medical Deal
5. MedTech Color Names 2022 Pitch Competition Winners